Zoledronic acid inhibits cancer treatment-induced bone loss in premenopausal patients with breast cancer who are receiving adjuvant endocrine treatment

被引：0
|
作者：
不详
机构：
来源：
BREAST | 2005年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [1] Zoledronic acid in the prevention of cancer treatment-induced bone loss in postmenopausal women receiving letrozole as adjuvant therapy for early breast cancer
    不详
    BREAST, 2005, 14 : S44 - S44
  • [2] Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: A report from the Austrian Breast and Colorectal Cancer Study Group
    Gnant, Michael F. X.
    Mlineritsch, Brigitte
    Luschin-Ebengreuth, Gero
    Grampp, Stephan
    Kaessmann, Helmut
    Schmid, Marianne
    Menzel, Christian
    Piswanger-Soelkner, Jutta Claudia
    Galid, Arik
    Mittlboeck, Martina
    Hausmaninger, Hubert
    Jakesz, Raimund
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 820 - 828
  • [3] Zoledronic acid in the prevention of cancer treatment-induced bone loss in postmenopausal women receiving letrozole as adjuvant therapy for early breast cancer (ZO-FAST study)
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 48 - 48
  • [4] Cancer treatment-induced bone loss in patients with breast or prostate cancer
    Maxwell, C
    Viale, PH
    ONCOLOGY NURSING FORUM, 2005, 32 (03) : 589 - 601
  • [5] The effects of treatment-induced symptoms, depression and age on sexuality in premenopausal women with early breast cancer receiving adjuvant endocrine therapy
    Ribi, K.
    Luo, W.
    Burstein, H. J.
    Naughton, M. J.
    Chirgwin, J.
    Ansari, R. H.
    Walley, B. A.
    Salim, M.
    van der Westhuizen, A.
    Abdi, E.
    Francis, P. A.
    Budman, D. R.
    Kennecke, H.
    Harvey, V. J.
    Giobbie-Hurder, A.
    Fleming, G. F.
    Pagani, O.
    Regan, M. M.
    Bernhard, J.
    CANCER RESEARCH, 2017, 77
  • [6] Cancer Treatment-Induced Bone Loss in women with breast cancer
    Hadji, Peyman
    BONEKEY REPORTS, 2015, 4
  • [7] Cancer Treatment-Induced Bone Loss in Breast and Prostate Cancer
    Saad, Fred
    Adachi, Jonathan D.
    Brown, Jacques P.
    Canning, Leah A.
    Gelmon, Karen A.
    Josse, Robert G.
    Pritchard, Kathleen I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (33) : 5465 - 5476
  • [8] MANAGMENT OF BREAST CANCER TREATMENT-INDUCED BONE LOSS
    Pattapola, Shyanthi
    Nandagudi, Anupama
    RHEUMATOLOGY, 2017, 56 : 100 - 101
  • [9] Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy
    Ribi, Karin
    Luo, Weixiu
    Walley, Barbara A.
    Burstein, Harold J.
    Chirgwin, Jacquie
    Ansari, Rafat H.
    Salim, Muhammed
    van der Westhuizen, Andre
    Abdi, Ehtesham
    Francis, Prudence A.
    Chia, Stephen
    Harvey, Vernon J.
    Giobbie-Hurder, Anita
    Fleming, Gini F.
    Pagani, Olivia
    Di Leo, Angelo
    Colleoni, Marco
    Gelber, Richard D.
    Goldhirsch, Aron
    Coates, Alan S.
    Regan, Meredith M.
    Bernhard, Juerg
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (02) : 347 - 359
  • [10] Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy
    Karin Ribi
    Weixiu Luo
    Barbara A. Walley
    Harold J. Burstein
    Jacquie Chirgwin
    Rafat H. Ansari
    Muhammed Salim
    Andre van der Westhuizen
    Ehtesham Abdi
    Prudence A. Francis
    Stephen Chia
    Vernon J. Harvey
    Anita Giobbie-Hurder
    Gini F. Fleming
    Olivia Pagani
    Angelo Di Leo
    Marco Colleoni
    Richard D. Gelber
    Aron Goldhirsch
    Alan S. Coates
    Meredith M. Regan
    Jürg Bernhard
    Breast Cancer Research and Treatment, 2020, 181 : 347 - 359
12345